Viewing Study NCT03057106


Ignite Creation Date: 2025-12-26 @ 4:01 PM
Ignite Modification Date: 2025-12-31 @ 9:30 PM
Study NCT ID: NCT03057106
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-29
First Post: 2017-02-15
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC
Sponsor: Canadian Cancer Trials Group
Organization: